Literature DB >> 19248685

Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury.

Darric E Baty1, Ming Zhang, Hongbo Li, Carolyn J Erb, Martin W Adler, Doina Ganea, Christopher M Loftus, Jack I Jallo, Ronald F Tuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19248685

Source DB:  PubMed          Journal:  Clin Neurosurg        ISSN： 0069-4827


× No keyword cloud information.
  7 in total

1.  Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression.

Authors:  Sabina Adhikary; Virginia P Kocieda; Jui-Hung Yen; Ronald F Tuma; Doina Ganea
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

2.  Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.

Authors:  Rebecca Hartzell Robinson; Joseph J Meissler; Jessica M Breslow-Deckman; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

Review 3.  Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Authors:  P Pacher; R Mechoulam
Journal:  Prog Lipid Res       Date:  2011-02-02       Impact factor: 16.195

4.  Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury.

Authors:  Sabina Adhikary; Hongbo Li; Joshua Heller; Mario Skarica; Ming Zhang; Doina Ganea; Ronald F Tuma
Journal:  J Neurotrauma       Date:  2011-10-04       Impact factor: 5.269

5.  A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10.

Authors:  Rebecca H Robinson; Joseph J Meissler; Xiaoxuan Fan; Daohai Yu; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-16       Impact factor: 4.147

Review 6.  Modulating the endocannabinoid system in human health and disease--successes and failures.

Authors:  Pál Pacher; George Kunos
Journal:  FEBS J       Date:  2013-04-22       Impact factor: 5.542

7.  Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.

Authors:  Guy A Cabral; Thomas J Rogers; Aron H Lichtman
Journal:  J Neuroimmune Pharmacol       Date:  2015-06-09       Impact factor: 4.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.